The $390 figure comes from an average of verified analyst targets rather than any single outlook. Recent projections split into bullish and more measured groups. On the optimistic side are Stifel at $460 with a Buy rating, RBC Capital at $500 with Outperform, J.P. Morgan at $465, Jefferies at $450, Evercore ISI at $452, Roth MKM at $450, Citi at $430, Needham at $425, and BofA at $450 though rated Hold. More conservative views include TD Cowen lowering its target to $300 with a Hold rating in mid-October, Susquehanna in the $275–$310 zone, Barclays near $325, and UBS at $425. Aggregators show averages in the mid-$300s to low-$390s depending on the sample. The broad spread from $153 to $500 indicates analysts are debating valuation and timing rather than growth prospects. Northland Capital downgraded to Market Perform in early October purely on valuation while still seeing estimates rise.
As of late October 2026, ALAB traded near $286 after moving between roughly $257 and $287 following the second-quarter report. Achieving $390 would imply about 36% upside at a time when the stock trades around 40 times trailing revenue per third-party estimates. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry. The path likely depends on continued execution with connectivity products including Aries PCIe/CXL retimers, the Scorpio X fabric switch, and Leo memory controllers, along with a wider customer ramp for Scorpio X beyond the lead account. A return toward earlier highs would require both earnings delivery and some stabilization of the multiple after the October compression.
Fundamentals continue to look solid. Second-quarter 2026 revenue reached $392.4 million, up about 104% year over year, while non-GAAP EPS of $0.80 topped the $0.69 consensus. Management guided third-quarter revenue to $540–$560 million, a roughly 40% sequential increase, with non-GAAP EPS of $1.16–$1.21 and a non-GAAP operating margin near 43%. Broadening hyperscaler demand and product validation by major chipmakers remain central to the positive case.
Valuation and concentration stand out as the main hurdles. Third-party analysis points to the top five customers accounting for around 90% of sales, so any delay in Scorpio X’s second-wave ramp could prompt further de-rating. TD Cowen’s reduction to $300 and Northland’s downgrade were both framed around price rather than fundamentals. Guidance shortfalls, margin pressure, or slower AI-related spending could hold the multiple—and the stock—below $390.
The 52-week high near $500 remains a psychological and chart-based resistance level, with the stock recently more than 40% below that peak. The $257 area provided short-term support during the October pullback before the rebound toward $286. A sustained recovery would likely need to reclaim the $300 level where TD Cowen’s revised target and recent selling pressure meet. I ran a quick scan with Tickeron’s AI Real Time Patterns to monitor any emerging formations.
Analyst targets generally reflect a roughly 12-month horizon, though individual firms vary. The next catalyst is the third-quarter report set for November 3, 2026, where investors will focus on whether revenue reaches the upper end of guidance and whether the Scorpio X multi-customer ramp stays on track. Later analyst updates, hyperscaler capital-expenditure commentary, and any signs of customer diversification will also be relevant.
In my own workflow I often review Tickeron’s AI Daily Buy/Sell Signals to stay on top of shifting conditions across thousands of names. The tool applies artificial intelligence to generate Buy, Sell, or Hold signals based on technical behavior and market changes, which can be especially useful for a volatile name like ALAB. It serves as one additional input alongside fundamentals and valuation when evaluating whether the stock can build toward higher levels.
The $390 target is simply the calculated average of current analyst price targets, not a forecast or guarantee. It sits about 36% above the recent price near $286, a gap that would require both continued earnings acceleration and some re-expansion of a still-demanding valuation. Support comes from record revenue, strong guidance, and product momentum, while the wide $153–$500 target range, customer concentration, and the October valuation reset argue for caution. The third-quarter report and Scorpio X’s multi-customer ramp are the next key signposts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
ALAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 17 of 19 cases where ALAB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 89%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ALAB's RSI Oscillator exited the oversold zone, 12 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 23 of 28 cases where ALAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
Following a +14.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALAB advanced for three days, in 148 of 166 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Aroon Indicator entered an Uptrend today. In 155 of 176 cases where ALAB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 88%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALAB as a result. In 36 of 44 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.
The Moving Average Convergence Divergence Histogram (MACD) for ALAB turned negative on October 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 29 similar instances when the indicator turned negative. In 24 of the 29 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
ALAB moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for ALAB crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 4 of 4 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. ALAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 80 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ALAB's P/B Ratio (29.878) is very high in comparison to the industry average of (6.607). P/E Ratio (136.959) is within average values for comparable stocks, (23.000). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.761). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (40.650) is also within normal values, averaging (45.794).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors